These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38212708)

  • 1. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
    Li X; Li J; Li J; Liu N; Zhuang L
    BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.
    Xiao Y; Zhang G; Wang L; Liang M
    Front Endocrinol (Lausanne); 2022; 13():1069528. PubMed ID: 36518242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
    Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
    Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
    Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
    Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer.
    Hong J; Lin X; Hu X; Wu X; Fang W
    Curr Gene Ther; 2021; 21(4):280-289. PubMed ID: 33045967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Biomarkers Associated with the Prognoses of Colorectal Cancer Patients.
    Fang Y; Zhan X
    Digestion; 2023; 104(2):148-162. PubMed ID: 36577392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis.
    Wang XQ; Xu SW; Wang W; Piao SZ; Mao XL; Zhou XB; Wang Y; Wu WD; Ye LP; Li SW
    Front Genet; 2021; 12():635863. PubMed ID: 33719345
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.